MRC Population Health Research Unit, Nuffield Department of Population Health, Richard Doll Building, Old Road Campus, Roosevelt Drive, Oxford OX3 7LF, UK.
Department of Cardiology, Inselspital, Bern University Hospital, Freiburgstrasse 4, 3010 Bern, Switzerland.
Cardiovasc Res. 2022 May 6;118(6):1385-1412. doi: 10.1093/cvr/cvab342.
Since its emergence in early 2020, the novel severe acute respiratory syndrome coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels, and there have been repeated outbreaks across the globe. The aim of this two-part series is to provide practical knowledge and guidance to aid clinicians in the diagnosis and management of cardiovascular disease (CVD) in association with COVID-19.
A narrative literature review of the available evidence has been performed, and the resulting information has been organized into two parts. The first, reported here, focuses on the epidemiology, pathophysiology, and diagnosis of cardiovascular (CV) conditions that may be manifest in patients with COVID-19. The second part, which will follow in a later edition of the journal, addresses the topics of care pathways, treatment, and follow-up of CV conditions in patients with COVID-19.
This comprehensive review is not a formal guideline but rather a document that provides a summary of current knowledge and guidance to practicing clinicians managing patients with CVD and COVID-19. The recommendations are mainly the result of observations and personal experience from healthcare providers. Therefore, the information provided here may be subject to change with increasing knowledge, evidence from prospective studies, and changes in the pandemic. Likewise, the guidance provided in the document should not interfere with recommendations provided by local and national healthcare authorities.
自 2020 年初新型严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）引发 2019 冠状病毒病（COVID-19）以来，该病毒已达到大流行水平，并在全球范围内多次爆发。本系列文章分为两部分，旨在为临床医生提供与 COVID-19 相关的心血管疾病（CVD）诊断和管理的实用知识和指导。
对现有证据进行了叙述性文献回顾，并将所得信息组织成两部分。第一部分，本文报告，重点介绍可能在 COVID-19 患者中表现出来的心血管（CV）疾病的流行病学、病理生理学和诊断。第二部分将在该杂志的后续版本中发表，讨论 COVID-19 患者 CV 疾病的护理路径、治疗和随访主题。
这篇综述不是正式指南，而是一份为管理 CVD 和 COVID-19 患者的临床医生提供当前知识和指导的文件。建议主要是医疗保健提供者观察和个人经验的结果。因此，随着知识的增加、前瞻性研究的证据以及大流行的变化，这里提供的信息可能会发生变化。同样，本文档中提供的指南不应干扰当地和国家卫生当局提供的建议。
